Excellent research Sokol. Thanks!
#8 was especially interesting: Aging is a common risk factor for the occurrence and development of many diseases, such as Parkinson’s disease, Alzheimer’s disease, diabetes, hypertension, atherosclerosis and coronary heart disease, and cancer, among others, and is a key problem threatening the health and life expectancy of the elderly. Oxidative damage is an important mechanism involved in aging.
Gee that about sum up current and projected 273 applications.
#1 shows a huge potential market: Reactive oxidative species (ROS) toxicity remains an undisputed cause and link between Alzheimer’s disease (AD) and Type-2 Diabetes Mellitus (T2DM). Patients with both AD and T2DM have damaged, oxidized DNA, RNA, protein and lipid products that can be used as possible disease progression markers.
Alzheimer has been informally called type 3 diabetes. If 273 works/helps with Type 2 diabetes, the market for 273 doubles. I don't think Anavex has ever discussed this, but it is a logical follow on for myszy studies at least.